ALFA Filings
Every announcement, straight from the exchange
Every regulatory approval announcement on NSE and BSE that our alert engine sent, newest first.
Time
346 announcements with these filters
AstraZeneca Pharma received CDSCO approval to market Enhertu for an additional breast cancer indication in India. This regulatory milestone expands the drug's therapeutic reach and commercial potential.
Alacrity Securities received SEBI registration as a Depository Participant. This enables the company to expand its financial services offerings.
Nitiraj Engineers Limited received DGCA Type Certification for its 'NADR10' agricultural drone. This milestone enables commercial manufacturing and marketing within India's agri-technology sector.
Concord Biotech received USFDA approval for Tofacitinib Tablets (5mg and 10mg). The approval targets a US$ 500 million market, strengthening the company's US pharmaceutical footprint.
Nuvama Wealth Management received SEBI registration to launch its mutual fund business. This milestone allows the group to expand its integrated wealth and asset management offerings.
Ad-Manum Finance received RBI approval for appointing Ms. Neha Singh as Whole-Time Director and Mr. Pramod Shrivastava as Chairman. This regulatory clearance validates leadership changes at the NBFC.
The Ministry of Mines has appointed Shri Anupam Misra as Chairman & Managing Director of Hindustan Copper. His tenure begins July 2026, ensuring leadership continuity for the CPSE.
Nibe Limited's subsidiary obtained a DPIIT license for firearms manufacturing and testing. This authorization significantly expands the company's capabilities within the Indian defense manufacturing sector.
Suryoday Small Finance Bank received RBI approval for the re-appointment of its Joint Statutory Auditors for FY2026-27. This regulatory clearance ensures continuity in the bank's audit processes.
EPW India's subsidiary, Renavart Recyclers, received hazardous waste authorization from the Telangana Pollution Control Board. This regulatory approval enables full-fledged commencement of business operations until 2031.
Vital Chemtech's subsidiary received a Provisional Consent Order from the Gujarat Pollution Control Board. Valid until 2031, this authorization permits manufacturing operations at its Dahej-III facility.
Alembic Pharmaceuticals received final USFDA approval for Haloperidol Tablets used in treating psychotic and Tourette’s disorders. This strengthens the company's generic portfolio in the US market.
Lupin received U.S. FDA approval for Ranluspec, an interchangeable biosimilar for Lucentis. This milestone expands the company's ophthalmology portfolio in the American market.
Orient Cement received 'no objection' letters from BSE and NSE for its merger with Ambuja Cements. This regulatory clearance allows the company to approach the NCLT.
Ambuja Cements received 'no objection' from NSE and BSE for its merger with ACC Limited. The company will now proceed with NCLT filing for final approval.
AvenuesAI's subsidiary received in-principle approval for a UAE Retail Payment Services license. This regulatory milestone supports strategic expansion into the region's digital payments market.
Aurobindo Pharma received final US FDA approval for Tofacitinib Tablets used in treating rheumatoid arthritis. The product will be manufactured by its subsidiary and launched immediately.
Purple Finance Limited received RBI approval for acquisition of control and shareholding changes. This enables the proposed open offer and equity share warrant issuance.
Natco Pharma and Lupin received U.S. FDA approval for Eribulin Mesylate Injection. The product targets a USD 43.7 million market for metastatic breast cancer treatment.
Lupin and Natco received U.S. FDA approval for Eribulin Mesylate Injection. The reference drug has estimated annual U.S. sales of ₹415.15 Crore.
Engineers India received Ministry approval to extend Shri Praveen M. Khanooja's additional charge as CMD for three months. This ensures management continuity pending a regular appointment.
Concord Biotech received USFDA approval for its Mycophenolate Mofetil Oral Suspension ANDA. This approval strengthens the company's position in the US$ 30 million U.S. market.
Indian Overseas Bank received a perpetual license from IFSCA to establish an IFSC Banking Unit at GIFT City, Gujarat. This regulatory approval enables the bank to expand operations.
Shelter Pharma received a manufacturing license renewal for Ayurvedic products from the Government of Gujarat. The license is valid until September 2030, ensuring uninterrupted operations.
Prime Cable Industries obtained a BIS license for manufacturing aluminium alloy stranded conductors valid until 2031. This approval enables entry into high-value government and utility markets.
KD Green Industries subsidiary KDIPL received UNNATI 2024 scheme registration from DPIIT. The approval enables the unit to access capital incentives for its upcoming steel fabrication project.
Equitas Small Finance Bank received RBI approval for Mirae Asset Mutual Fund to acquire up to 9.50% stake. The approval remains valid for one year.
Jainik Power Cables obtained key BIS certifications for its aluminium conductors and power cables. This regulatory milestone enables the company to commence large-scale commercial manufacturing operations.
Cochin Shipyard received government approval to extend Shri Jose V J's additional charge as Chairman & Managing Director for three months. This ensures leadership continuity during the transition.
India Pesticides Limited received EU Technical Equivalence approval for its Fungicide product. This regulatory milestone enables European market access and strengthens the company's global export strategy.